{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:39:59Z","timestamp":1790192399814,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,5,1]]},"DOI":"10.1038\/sj.bmt.1703008","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T15:42:22Z","timestamp":1032277342000},"page":"939-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review"],"prefix":"10.1038","volume":"27","author":[{"given":"LJ","family":"Ayash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Uberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ER","family":"Broun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PT","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,7,2]]},"reference":[{"key":"BF1703008_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199707243370406","volume":"337","author":"GJ Bosl","year":"1997","unstructured":"Bosl GJ, Motzer RJ . Testicular germ-cell cancer New Engl J Med 1997 337: 242\u2013253","journal-title":"New Engl J Med"},{"key":"BF1703008_CR2","first-page":"5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA . Cancer statistics, 1997 CA 1997 47: 5\u201327","journal-title":"CA"},{"key":"BF1703008_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.7326\/0003-4819-109-7-540","volume":"109","author":"PJ Loehrer","year":"1988","unstructured":"Loehrer PJ, Lauer R, Roth BJ et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide Ann Int Med 1988 109: 540\u2013546","journal-title":"Ann Int Med"},{"key":"BF1703008_CR4","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1200\/JCO.1991.9.9.1549","volume":"9","author":"A Harstrick","year":"1991","unstructured":"Harstrick A, Schmoll H-J, Wilke H et al. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma J Clin Oncol 1991 9: 1549\u20131555","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR5","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1200\/JCO.1997.15.7.2559","volume":"15","author":"JA McCaffrey","year":"1997","unstructured":"McCaffrey JA, Mazumdar M, Bajorin DF et al. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival J Clin Oncol 1997 15: 2559\u20132563","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR6","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","volume":"16","author":"PJ Loehrer","year":"1998","unstructured":"Loehrer PJ, Gonin R, Nichols CR et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor J Clin Oncol 1998 16: 2500\u20132504","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","volume":"4","author":"R Birch","year":"1986","unstructured":"Birch R, Williams SD, Cone A et al. Prognostic factors for favorable outcome in disseminated germ cell tumors J Clin Oncol 1986 4: 400\u2013407","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","volume":"8","author":"LH Einhorn","year":"1990","unstructured":"Einhorn LH . Treatment of testicular cancer: a new and improved model (Karnofsky Memorial Lecture) J Clin Oncol 1990 8: 1777\u20131781","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR9","first-page":"3403","volume":"43","author":"GJ Bosl","year":"1983","unstructured":"Bosl GJ, Geller NL, Cirrincione C et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer Cancer Res 1983 43: 3403\u20133407","journal-title":"Cancer Res"},{"key":"BF1703008_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1200\/JCO.1992.10.1.85","volume":"10","author":"GM Mead","year":"1992","unstructured":"Mead GM, Stenning SP, Parkinson MC et al. The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors J Clin Oncol 1992 10: 85\u201394","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","volume":"15","author":"Group International Germ Cell Cancer Coll","year":"1997","unstructured":"International Germ Cell Cancer Collaborative Group . International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers J Clin Oncol 1997 15: 594\u2013603","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","volume":"316","author":"SD Williams","year":"1987","unstructured":"Williams SD, Birch R, Einhorn LH et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide New Engl J Med 1987 316: 1435\u20131440","journal-title":"New Engl J Med"},{"key":"BF1703008_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1200\/JCO.1988.6.8.1231","volume":"6","author":"GJ Bosl","year":"1988","unstructured":"Bosl GJ, Geller NL, Bajorin D et al. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good prognosis germ cell tumors J Clin Oncol 1988 6: 1231\u20131238","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","volume":"7","author":"LH Einhorn","year":"1989","unstructured":"Einhorn LH, Williams SD, Loehrer PJ et al. Evaluation of optimal duration of chemotherapy in favorable prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol J Clin Oncol 1989 7: 387\u2013391","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.1991.9.1.70","volume":"9","author":"AJ Wozniak","year":"1991","unstructured":"Wozniak AJ, Samson MK, Shah NT et al. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group Study J Clin Oncol 1991 9: 70\u201376","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1200\/JCO.1993.11.4.598","volume":"11","author":"DF Bajorin","year":"1993","unstructured":"Bajorin DF, Sarosdy MF, Pfister DG et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: a multiinstitutional study J Clin Oncol 1993 11: 598\u2013606","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR17","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.1993.11.7.1300","volume":"11","author":"JA Levi","year":"1993","unstructured":"Levi JA, Raghavan D, Harvey V et al. The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomas J Clin Oncol 1993 11: 1300\u20131305","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1200\/JCO.1995.13.2.470","volume":"13","author":"PJ Loehrer","year":"1995","unstructured":"Loehrer PJ, Johnson D, Elson P et al. Importance of bleomycin in favorable-prognosis germ cell tumors: an Eastern Cooperative Oncology Group trial J Clin Oncol 1995 13: 470\u2013476","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1200\/JCO.1997.15.5.1837","volume":"15","author":"R De Wit","year":"1997","unstructured":"De Wit R, Stoter G, Kaye SB et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group J Clin Oncol 1997 15: 1837\u20131843","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR20","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.1997.15.5.1844","volume":"15","author":"A Horwich","year":"1997","unstructured":"Horwich A, Sleijfer DT, Fossa SD et al. Randomized trial of bleomycin, etoposide and cisplatin compared with bleomycin, etoposide and carboplatin in good prognosis metastatic nonseminomatous germ cell cancer: a multiinstitutional Medical Research Council\/European Organization for Research and Treatment of Cancer Trial J Clin Oncol 1997 15: 1844\u20131852","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1200\/JCO.1998.16.2.702","volume":"16","author":"SB Saxman","year":"1998","unstructured":"Saxman SB, Finch D, Gonin R, Einhorn LH . Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide and cisplatin in favorable-prognosis germ cell tumors: the Indiana University Experience J Clin Oncol 1998 16: 702\u2013706","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1200\/JCO.1989.7.7.932","volume":"7","author":"CR Nichols","year":"1989","unstructured":"Nichols CR, Tricot G, Williams SD et al. Dose-intensive chemotherapy in refractory germ cell cancer \u2013 a phase I\/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation J Clin Oncol 1989 7: 932\u2013939","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR23","first-page":"325a (Abstr. 12","volume":"17","author":"PT Adams","year":"1998","unstructured":"Adams PT, Ayash L, Ratanatharathorn V et al. Phase I\/II high-dose chemotherapy with autologous stem cell support for testis cancer: the University of Michigan experience Proc Am Soc Clin Oncol 1998 17: 325a (Abstr. 1252)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1703008_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF1703008_CR25","volume-title":"Statistical Methods in Medical Research (2nd edn)","author":"P Armitage","year":"1987","unstructured":"Armitage P, Berry G . Statistical Methods in Medical Research (2nd edn) Blackwell Scientific: Oxford 1987"},{"key":"BF1703008_CR26","volume-title":"AJCC Cancer Staging Handbook","author":"ID Fleming","year":"1998","unstructured":"Fleming ID, Cooper JS, Henson DE et al (eds). AJCC Cancer Staging Handbook Lippincott-Raven: Philadelphia, PA 1998"},{"key":"BF1703008_CR27","first-page":"137","volume":"4","author":"HE Skipper","year":"1974","unstructured":"Skipper HE . Combination therapy: some concepts and results Cancer Chemother Rep 1974 4: 137\u2013145","journal-title":"Cancer Chemother Rep"},{"key":"BF1703008_CR28","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1073\/pnas.82.7.2158","volume":"82","author":"E Frei","year":"1985","unstructured":"Frei E, Cucchi C, Rosowsky A et al. Alkylating agent resistance: in vitro studies of human cell lines Proc Natl Acad Sci USA 1985 82: 2158\u20132162","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703008_CR29","first-page":"4379","volume":"46","author":"B Teicher","year":"1986","unstructured":"Teicher B, Cucchi C, Lee J et al. Alkylating agents: in vitro studies of cross-resistance patterns in human tumor cell lines Cancer Res 1986 46: 4379\u20134383","journal-title":"Cancer Res"},{"key":"BF1703008_CR30","first-page":"200","volume":"23","author":"F Schabel","year":"1978","unstructured":"Schabel F . Patterns of resistance and therapeutic synergism among alkylating agents Fund Cancer Chemother 1978 23: 200\u2013215","journal-title":"Fund Cancer Chemother"},{"key":"BF1703008_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/1097-0142(19840915)54:1+<1160::AID-CNCR2820541312>3.0.CO;2-P","volume":"54 (Suppl.\u20096)","author":"F Schabel","year":"1984","unstructured":"Schabel F, Griswold D, Corbett T . Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology Cancer 1984 54 (Suppl.\u20096): 1160\u20131167","journal-title":"Cancer"},{"key":"BF1703008_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00685733","volume":"36","author":"SA Holden","year":"1995","unstructured":"Holden SA, Teicher B, Ayash LJ et al. A preclinical model for sequential high-dose chemotherapy Cancer Chemother Pharmacol 1995 36: 61\u201364","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1703008_CR33","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1200\/JCO.1989.7.7.932","volume":"7","author":"CR Nichols","year":"1989","unstructured":"Nichols CR, Tricot PJ, Williams SD et al. Dose-intensive chemotherapy in refractory germ cell cancer \u2013 a phase I\/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation J Clin Oncol 1989 7: 932\u2013939","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1200\/JCO.1992.10.4.558","volume":"10","author":"CR Nichols","year":"1992","unstructured":"Nichols CR, Andersen J, Lazarus HM et al. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol J Clin Oncol 1992 10: 558\u2013563","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.7326\/0003-4819-117-2-124","volume":"117","author":"ER Broun","year":"1992","unstructured":"Broun ER, Nichols CR, Kneebone P et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue Ann Int Med 1992 117: 124\u2013128","journal-title":"Ann Int Med"},{"key":"BF1703008_CR36","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/1097-0142(19940315)73:6<1716::AID-CNCR2820730627>3.0.CO;2-L","volume":"73","author":"ER Broun","year":"1994","unstructured":"Broun ER, Nichols CR, Turns M et al. Early salvage therapy for germ cell cancer using high-dose chemotherapy with autologous bone marrow support Cancer 1994 73: 1716\u20131720","journal-title":"Cancer"},{"key":"BF1703008_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1605::AID-CNCR25>3.0.CO;2-0","volume":"79","author":"ER Broun","year":"1997","unstructured":"Broun ER, Nichols CR, Gize G et al. Tandem high-dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer Cancer 1997 79: 1605\u20131610","journal-title":"Cancer"},{"key":"BF1703008_CR38","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/jnci\/84.22.1703","volume":"84","author":"RJ Motzer","year":"1992","unstructured":"Motzer RJ, Bosl GJ . High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions J Natl Cancer Inst 1992 84: 1703\u20131709","journal-title":"J Natl Cancer Inst"},{"key":"BF1703008_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1097-0142(19920115)69:2<550::AID-CNCR2820690245>3.0.CO;2-D","volume":"69","author":"RJ Motzer","year":"1992","unstructured":"Motzer RJ, Gulati SC, Crown JP et al. High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors Cancer 1992 69: 550\u2013556","journal-title":"Cancer"},{"key":"BF1703008_CR40","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1200\/JCO.1996.14.4.1098","volume":"14","author":"RJ Motzer","year":"1996","unstructured":"Motzer RJ, Mazumdar M, Bosl GJ et al. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity J Clin Oncol 1996 14: 1098\u20131105","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR41","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1200\/JCO.1991.9.10.1860","volume":"9","author":"JP Lotz","year":"1991","unstructured":"Lotz JP, Machover D, Malassagne B et al. Phase I\u2013II study of two consecutive courses of high-dose epipodophyllotoxic, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors J Clin Oncol 1991 9: 1860\u20131870","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR42","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.1996.14.10.2638","volume":"14","author":"J Beyer","year":"1996","unstructured":"Beyer J, Kramar A, Mandanas R et al. High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables J Clin Oncol 1996 14: 2638\u20132645","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/07357909509031915","volume":"13","author":"S Rodenhuis","year":"1995","unstructured":"Rodenhuis S, van der Wall E, ten Bokkel Huinink WW et al. Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer Cancer Invest 1995 13: 355\u2013362","journal-title":"Cancer Invest"},{"key":"BF1703008_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0277-5379(91)90127-Y","volume":"27","author":"JP Droz","year":"1991","unstructured":"Droz JP, Pico JL, Ghosn M et al. Long-term survivors after salvage high-dose chemotherapy with bone marrow rescue in refractory germ cell cancer Eur J Cancer 1991 27: 831\u2013835","journal-title":"Eur J Cancer"},{"key":"BF1703008_CR45","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1200\/JCO.1994.12.6.1223","volume":"12","author":"W Siegert","year":"1994","unstructured":"Siegert W, Beyer J, Strohscheer I et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem cell transplantation in relapsed or refractory germ cell cancer: a phase I\/II study J Clin Oncol 1994 12: 1223\u20131231","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/1097-0142(19950201)75:3<874::AID-CNCR2820750320>3.0.CO;2-Q","volume":"75","author":"JP Lotz","year":"1995","unstructured":"Lotz JP, Andre T, Donsimoni R et al. High-dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults Cancer 1995 75: 874\u2013885","journal-title":"Cancer"},{"key":"BF1703008_CR47","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1200\/JCO.1996.14.10.2631","volume":"14","author":"K Margolin","year":"1996","unstructured":"Margolin K, Doroshow JH, Ahn C et al. Treatment with germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem cell support J Clin Oncol 1996 14: 2631\u20132637","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR48","first-page":"53","volume":"7","author":"ER Broun","year":"1991","unstructured":"Broun ER, Nichols CR, Tricot PJ et al. High-dose carboplatin\/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors Bone Marrow Transplant 1991 7: 53\u201356","journal-title":"Bone Marrow Transplant"},{"key":"BF1703008_CR49","first-page":"321a (Abstr. 12","volume":"17","author":"S Bhatia","year":"1998","unstructured":"Bhatia S, Cornetta K, Broun ER et al. High-dose chemotherapy with peripheral stem cell or autologous bone marrow transplant as initial salvage chemotherapy for testicular cancer Proc Am Soc Clin Oncol 1998 17: 321a (Abstr. 1239)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF1703008_CR50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/bjc.1993.392","volume":"68","author":"MJ Barnett","year":"1993","unstructured":"Barnett MJ, Coppin CML, Murray N et al. High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumors Br J Cancer 1993 68: 594\u2013598","journal-title":"Br J Cancer"},{"key":"BF1703008_CR51","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.1997.15.7.2546","volume":"15","author":"RJ Motzer","year":"1997","unstructured":"Motzer RJ, Mazumdar M, Bajorin DF et al. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors J Clin Oncol 1997 15: 2546\u20132552","journal-title":"J Clin Oncol"},{"key":"BF1703008_CR52","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","volume":"341","author":"KK Matthay","year":"1999","unstructured":"Matthay KK, Villablanca JG, Seeger RC et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid New Engl J Med 1999 341: 1165\u20131173","journal-title":"New Engl J Med"},{"key":"BF1703008_CR53","first-page":"841","volume":"26","author":"K Iida","year":"1999","unstructured":"Iida K, Kawai K, Hayashi H et al. Cases of refractory testicular cancer treated with all-trans-retinoic acid Jap J Cancer Chemother 1999 26: 841\u2013844","journal-title":"Jap J Cancer Chemother"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703008","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:00:51Z","timestamp":1648076451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,5,1]]}},"alternative-id":["BF1703008"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703008","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]},"assertion":[{"value":"26 September 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}